Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery

Journal of Cataract and Refractive Surgery
Majid MoshirfarPaul C Kang

Abstract

We report the first 2 cases of bacterial keratitis resistant to fourth-generation fluoroquinolones after laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). The first patient had Pseudomonas aeruginosa keratitis after PRK despite treatment with moxifloxacin. The second patient was on gatifloxacin post-LASIK when she had methicillin-resistant Staphylococcus aureus (MRSA) keratitis diagnosed. In both cases, culture susceptibilities showed isolates resistant to moxifloxacin and gatifloxacin, and treatment with topical aminoglycosides and surgical intervention was necessary to effect a cure. These cases show the potential limitations in the coverage of these antibiotics.

References

Sep 1, 1995·Survey of Ophthalmology·T Seiler, P J McDonnell
May 1, 1996·Archives of Ophthalmology·J C FultonC J Rapuano
Jul 1, 1996·The British Journal of Ophthalmology·C L AstinA D McG Steele
Sep 1, 1996·American Journal of Otolaryngology·I M DunyaJ W Shore
Jul 1, 1997·Journal of Cataract and Refractive Surgery·W R WeeJ H Lee
Feb 19, 1998·American Journal of Ophthalmology·R Lim-Bon-SiongJ S Pepose
Jan 15, 1999·Journal of Cataract and Refractive Surgery·S Malling
Feb 25, 1999·American Journal of Ophthalmology·R T Lin, R K Maloney
Jul 16, 1999·Ophthalmology·M H GoldsteinY J Gordon
Aug 12, 1999·Ophthalmology·A C Gulani
Mar 20, 2001·Journal of Cataract and Refractive Surgery·J C Rudd, M Moshirfar
Jun 27, 2001·Ophthalmology·G A KouyoumdjianR E Damiano
Sep 22, 2001·Journal of Cataract and Refractive Surgery·R S Rubinfeld, G J Negvesky
Apr 5, 2002·American Journal of Ophthalmology·Rookaya MatherRegis P Kowalski
Apr 17, 2002·Journal of Cataract and Refractive Surgery·Werner FörsterHolger Busse
Jan 21, 2003·Emerging Infectious Diseases·W Michael Scheld
Mar 8, 2003·Ophthalmology·Carol L KarpWilliam W Culbertson
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louis D Saravolatz, James Leggett
Nov 26, 2009·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·R Todd AllenFrank M Phillips

❮ Previous
Next ❯

Citations

Jan 12, 2007·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·W Behrens-Baumann, U Pleyer
Jun 23, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·T Ness
Feb 11, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·W Behrens-BaumannT Ness
Feb 22, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N SzentmáryB Seitz
Nov 19, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Karim MakdoumiSven Crafoord
Dec 25, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Jiong WangNóra Szentmáry
Mar 12, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Natalie A AfshariRon A Adelman
Mar 26, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Melissa E SandersMary E Marquart
Sep 1, 2006·Photomedicine and Laser Surgery
Nov 26, 2010·Cornea·Karim MakdoumiSven Crafoord
Dec 20, 2007·Current Opinion in Ophthalmology·Francis Char DeCroos, Natalie A Afshari
May 15, 2007·Current Opinion in Infectious Diseases·Philip Aloysius Thomas, Pitchairaj Geraldine
Jun 5, 2007·American Journal of Veterinary Research·Eric C LedbetterJanet M Scarlett
Feb 28, 2013·Expert Opinion on Pharmacotherapy·Darlene Miller
Mar 28, 2009·Current Medical Research and Opinion·Michael E TepedinoTimothy L Comstock
Jul 26, 2011·Journal of Cataract and Refractive Surgery·Mark PackerUNKNOWN ASCRS Cataract Clinical Committee
Dec 17, 2009·Ophthalmology·Fernando LlovetJulio Baviera
Mar 3, 2009·Journal of Cataract and Refractive Surgery·Yuichi HoriYasuo Tano
Jan 26, 2013·Journal of Refractive Surgery·Daniel I BettisMajid Moshirfar
Feb 27, 2008·Journal of Cataract and Refractive Surgery·Thomas J Liesegang
Oct 30, 2007·Journal of Cataract and Refractive Surgery·Nick Mamalis
Jul 31, 2007·Journal of Cataract and Refractive Surgery·Vishal JhanjiJeewan Titiyal
Feb 6, 2007·Journal of Cataract and Refractive Surgery·Maria Woodward, J Bradley Randleman
May 18, 2012·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Namrata SharmaJeewan S Titiyal
Jul 6, 2010·Microbes and Infection·Ashok KumarFu-Shin X Yu
May 15, 2013·Ophthalmic Epidemiology·Catherine E OldenburgNisha R Acharya
Jan 18, 2018·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Sujaya SinghSubrayan Visvaraja
Dec 21, 2019·Indian Journal of Ophthalmology·Rui TianHui Zhang
Nov 20, 2009·European Journal of Ophthalmology·Bhavna ChawlaGita Satpathy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.